{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:49:28Z","timestamp":1778662168347,"version":"3.51.4"},"reference-count":305,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004101","name":"Lady Tata Memorial Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/FST\/LSI-574\/2013"],"award-info":[{"award-number":["SR\/FST\/LSI-574\/2013"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.neuint.2022.105380","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:06:47Z","timestamp":1655435207000},"page":"105380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Neuroprotective approaches to halt Parkinson's disease progression"],"prefix":"10.1016","volume":"158","author":[{"given":"Piyong","family":"sola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen Thaggikuppe","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamta","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowramma","family":"Byran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosahalli Veerabhadrappa","family":"Gangadharappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kusuma Kumari","family":"Garikapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2022.105380_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10534-018-0131-5","article-title":"Prevention of progression in Parkinson's disease","volume":"31","author":"Aaseth","year":"2018","journal-title":"Biometals"},{"key":"10.1016\/j.neuint.2022.105380_bib2","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1523\/JNEUROSCI.0636-16.2016","article-title":"A new glucocerebrosidase chaperone reduces \u03b1-synuclein and glycolipid levels in iPSC-derived dopaminergic neurons from patients with Gaucher disease and parkinsonism","volume":"36","author":"Aflaki","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib3","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1126\/science.1092666","article-title":"Global air quality and pollution","volume":"302","author":"Akimoto","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuint.2022.105380_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1126\/science.aar5683","article-title":"LRRK2 kinase in Parkinson's disease","volume":"360","author":"Alessi","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.neuint.2022.105380_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3171\/jns.2001.94.1.0043","article-title":"Pallidotomy for Parkinson disease: a review of contemporary literature","volume":"94","author":"Alkhani","year":"2001","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuint.2022.105380_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/10408444.2013.798719","article-title":"Parkinson's disease and pesticide exposure\u2013a new assessment","volume":"43","author":"Allen","year":"2013","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.neuint.2022.105380_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","article-title":"Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission","volume":"42","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2022.105380_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1212\/WNL.0b013e318245f476","article-title":"Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers","volume":"78","author":"Anheim","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105380_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/brain\/aws009","article-title":"Parkinson's disease, insulin resistance and novel agents of neuroprotection","volume":"136","author":"Aviles-Olmos","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2022.105380_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13311-014-0312-z","article-title":"Biometals and their therapeutic implications in Alzheimer's disease","volume":"12","author":"Ayton","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuint.2022.105380_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.23817","article-title":"Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease","volume":"73","author":"Ayton","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrm1666","article-title":"Autophagy: dual roles in life and death?","volume":"6","author":"Baehrecke","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuint.2022.105380_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049635","article-title":"Acidic nanoparticles are trafficked to lysosomes and restore an acidic lysosomal pH and degradative function to compromised ARPE-19 cells","volume":"7","author":"Baltazar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2022.105380_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.toxlet.2014.01.039","article-title":"Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases\u2014a mechanistic approach","volume":"230","author":"BAltazar","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuint.2022.105380_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuint.2022.105380_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mib.2013.12.003","article-title":"Intestinal barrier dysfunction triggered by invasive bacteria","volume":"17","author":"Barreau","year":"2014","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.neuint.2022.105380_bib305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-016-0408-2","article-title":"Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson\u2019s disease","volume":"5","author":"Barrenschee","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuint.2022.105380_bib18","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182904faa","article-title":"Safety\/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients","volume":"80","author":"Bartus","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105380_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mds.23442","article-title":"Bioactivity of AAV2\u2010neurturin gene therapy (CERE\u2010120): differences between Parkinson's disease and nonhuman primate brains","volume":"26","author":"Bartus","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib20","first-page":"9593","article-title":"Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy","volume":"vol. 113","author":"Bassil","year":"2016"},{"key":"10.1016\/j.neuint.2022.105380_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","article-title":"A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit","volume":"71","author":"B","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jnc.13425","article-title":"Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics","volume":"139","author":"Belaidi","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105380_bib23","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1093\/brain\/awh666","article-title":"Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease","volume":"128","author":"Berg","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2022.105380_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039953","article-title":"Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in mice","volume":"7","author":"Bian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2022.105380_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00441-018-2817-y","article-title":"Genetic risk factors in Parkinson's disease","volume":"373","author":"Billingsley","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuint.2022.105380_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nature13418","article-title":"The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy","volume":"510","author":"Bingol","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105380_bib27","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1096\/fj.04-1945fje","article-title":"Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase","volume":"18","author":"Block","year":"2004","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuint.2022.105380_bib28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tins.2009.05.009","article-title":"Air pollution: mechanisms of neuroinflammation and CNS disease","volume":"32","author":"Block","year":"2009","journal-title":"Trends in neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib29","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1096\/fj.12-210989","article-title":"Prenatal air pollution exposure induces neuroinflammation and predisposes offspring to weight gain in adulthood in a sex\u2010specific manner","volume":"26","author":"Bolton","year":"2012","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuint.2022.105380_bib30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105380_bib31","doi-asserted-by":"crossref","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","article-title":"The biology of influenza viruses","volume":"26","author":"Bouvier","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.neuint.2022.105380_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s004010000247","article-title":"\u03b1-Synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei","volume":"101","author":"Braak","year":"2001","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2022.105380_bib33","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","article-title":"Invited Article: nervous system pathology in sporadic Parkinson disease","volume":"70","author":"Braak","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105380_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2022.105380_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3233\/JPD-171191","article-title":"c-Abl and Parkinson's disease: mechanisms and therapeutic potential","volume":"7","author":"Brahmachari","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuint.2022.105380_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001854","article-title":"Glitazone treatment and incidence of Parkinson's disease among people with diabetes: a retrospective cohort study","volume":"12","author":"Brauer","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.neuint.2022.105380_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/exnr.1993.1042","article-title":"Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism","volume":"120","author":"Brouillet","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5414\/NPP30104","article-title":"Differential degeneration of the locus coeruleus in dementia subtypes","volume":"30","author":"Brunnstr\u00f6m","year":"2011","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.neuint.2022.105380_bib39","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"\u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuint.2022.105380_bib40","article-title":"\u03b1-synuclein and noradrenergic modulation of immune cells in Parkinson's disease pathogenesis","volume":"626","author":"Butkovich","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fnins.2013.00183","volume":"7","author":"Calder\u00f3n-Garcidue\u00f1as","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/161687","article-title":"Early Alzheimer's and Parkinson's disease pathology in urban children: friend versus foe responses\u2014it is time to face the evidence","author":"Calder\u00f3n-Garcidue\u00f1as","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuint.2022.105380_bib43","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/01926230390226645","article-title":"DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration","volume":"31","author":"Calderon-Garciduenas","year":"2003","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.neuint.2022.105380_bib44","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/0192623309340277","article-title":"Effects of a cyclooxygenase-2 preferential inhibitor in young healthy dogs exposed to air pollution: a pilot study","volume":"37","author":"Calder\u00f3n-Garcidue\u00f1as","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.neuint.2022.105380_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0192623307313011","article-title":"Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid \u03b2-42 and \u03b1-synuclein in children and young adults","volume":"36","author":"Calder\u00f3n-Garcidue\u00f1as","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.neuint.2022.105380_bib46","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ana.25074","article-title":"Traumatic brain injury in the prodromal period of Parkinson's disease: a large epidemiological study using medicare data","volume":"82","author":"Camacho\u2010Soto","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuroscience.2011.07.046","article-title":"Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model","volume":"194","author":"Carta","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2022.105380_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebri\u00e1n","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2022.105380_bib49","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"\u2018Rejuvenation\u2019protects neurons in mouse models of Parkinson's disease","volume":"447","author":"Chan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105380_bib50","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2022.105380_bib51","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1289\/EHP134","article-title":"Nanoscale particulate matter from urban traffic rapidly induces oxidative stress and inflammation in olfactory epithelium with concomitant effects on brain","volume":"124","author":"Cheng","year":"2016","journal-title":"Environ. health perspect."},{"key":"10.1016\/j.neuint.2022.105380_bib52","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.3390\/ijms21072464","article-title":"Historical perspective: models of Parkinson's disease","volume":"21","author":"Chia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2022.105380_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/nn0614-755","article-title":"Pacemaker's burden","volume":"17","author":"Cho","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00702-016-1616-4","article-title":"Gene therapy targeting mitochondrial pathway in Parkinson's disease","volume":"124","author":"Choong","year":"2017","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2022.105380_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuron.2014.02.018","article-title":"Retromer mediates a discrete route of local membrane delivery to dendrites","volume":"82","author":"Choy","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2022.105380_bib56","article-title":"NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.(vol 14, pg 795, 2015)","volume":"14","author":"Christine","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.nbd.2010.08.022","article-title":"\u03b1-Synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson's disease","volume":"41","author":"Chu","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2022.105380_bib58","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105380_bib59","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/mds.25978","article-title":"Systemic exosomal siRNA delivery reduced alpha\u2010synuclein aggregates in brains of transgenic mice","volume":"29","author":"Cooper","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib60","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00204-013-1017-5","article-title":"Manganese-exposed developing rats display motor deficits and striatal oxidative stress that are reversed by Trolox","volume":"87","author":"Cordova","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuint.2022.105380_bib61","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1093\/hmg\/ddu244","article-title":"The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy","volume":"23","author":"Cornelissen","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2022.105380_bib62","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1523\/JNEUROSCI.23-10-04081.2003","article-title":"Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease","volume":"23","author":"Crocker","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib63","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.cell.2015.08.030","article-title":"Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity","volume":"163","author":"Da Fonseca","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2022.105380_bib64","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of \u03b1-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib65","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2022.105380_bib66","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson's disease: autoimmunity and neuroinflammation","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.neuint.2022.105380_bib67","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","article-title":"TFEB-mediated autophagy rescues midbrain dopamine neurons from \u03b1-synuclein toxicity","volume":"110","author":"Decressac","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2022.105380_bib68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1189\/jlb.0702372","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase\u2010activating polypeptide inhibit the production of inflammatory mediators by activated microglia","volume":"73","author":"Delgado","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.neuint.2022.105380_bib69","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","article-title":"Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease","volume":"115","author":"Dickson","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2022.105380_bib70","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.mehy.2014.09.025","article-title":"M. paratuberculosis and Parkinson's disease\u2013is this a trigger","volume":"83","author":"Dow","year":"2014","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuint.2022.105380_bib71","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.immuni.2009.08.009","article-title":"Immune responses to the microbiota at the intestinal mucosal surface","volume":"31","author":"Duerkop","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.neuint.2022.105380_bib72","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201489729","article-title":"USP8 regulates mitophagy by removing K6\u2010linked ubiquitin conjugates from parkin","volume":"33","author":"Durcan","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2022.105380_bib73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jtemb.2014.05.007","article-title":"The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases","volume":"31","author":"Dusek","year":"2015","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.neuint.2022.105380_bib74","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1523\/JNEUROSCI.20-24-09126.2000","article-title":"Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease","volume":"20","author":"Eberhardt","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib75","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ana.21717","article-title":"Professional exposure to pesticides and Parkinson disease","volume":"66","author":"Elbaz","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib76","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1016\/j.bmcl.2017.07.075","article-title":"Current approaches to the treatment of Parkinson's disease","volume":"27","author":"Ellis","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuint.2022.105380_bib77","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1073858415616558","article-title":"LRRK2 at the crossroad between autophagy and microtubule trafficking: insights into Parkinson's disease","volume":"23","author":"Esteves","year":"2017","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuint.2022.105380_bib78","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2022.105380_bib79","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.envres.2007.03.002","article-title":"A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities","volume":"104","author":"Finkelstein","year":"2007","journal-title":"Environ. Res."},{"key":"10.1016\/j.neuint.2022.105380_bib80","first-page":"152","article-title":"14-3-3 proteins in neurological disorders","volume":"3","author":"Foote","year":"2012","journal-title":"Int. j. biochem. mol. biol."},{"key":"10.1016\/j.neuint.2022.105380_bib81","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.expneurol.2017.10.001","article-title":"Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease","volume":"298","author":"Francardo","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib82","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1523\/JNEUROSCI.5314-13.2014","article-title":"Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models","volume":"34","author":"Games","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib83","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression","volume":"29","author":"Gao","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neuint.2022.105380_bib84","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of \u03b1-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"Gao","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib85","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1289\/ehp.1003013","article-title":"Neuroinflammation and \u03b1-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease","volume":"119","author":"Gao","year":"2011","journal-title":"Environ. health perspect."},{"key":"10.1016\/j.neuint.2022.105380_bib86","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ana.20549","article-title":"Trophic factor distribution predicts functional recovery in parkinsonian monkeys","volume":"58","author":"Gash","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib87","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/380252a0","article-title":"Functional recovery in parkinsonian monkeys treated with GDNF","volume":"380","author":"Gash","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105380_bib88","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2022.105380_bib89","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease\u2010specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib90","series-title":"The Relationship between Pesticides and Parkinson's","author":"Gilbert","year":"2018"},{"key":"10.1016\/j.neuint.2022.105380_bib91","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","article-title":"Direct brain infusion of glial cell line\u2013derived neurotrophic factor in Parkinson disease","volume":"9","author":"Gill","year":"2003","journal-title":"Nat. med."},{"key":"10.1016\/j.neuint.2022.105380_bib92","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","article-title":"Environmental toxins and Parkinson's disease","volume":"54","author":"Goldman","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuint.2022.105380_bib93","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1212\/WNL.48.3.650","article-title":"Occupational exposures to metals as risk factors for Parkinson's disease","volume":"48","author":"Gorell","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105380_bib94","first-page":"83","article-title":"Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease","volume":"5","author":"Graham","year":"1984","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2022.105380_bib95","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.neuroscience.2008.10.023","article-title":"Effects of calpain inhibition on dopaminergic markers and motor function following intrastriatal 6-hydroxydopamine administration in rats","volume":"158","author":"Grant","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2022.105380_bib96","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3727\/096368908784423256","article-title":"Intraputamenal infusion of exogenous neurturin protein restores motor and dopaminergic function in the globus pallidus of MPTP-lesioned rhesus monkeys","volume":"17","author":"Grondin","year":"2008","journal-title":"Cell Transplant."},{"key":"10.1016\/j.neuint.2022.105380_bib97","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/brain\/awf234","article-title":"Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys","volume":"125","author":"Grondin","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2022.105380_bib98","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","article-title":"New insights into the complex role of mitochondria in Parkinson's disease","volume":"177","author":"Gr\u00fcnewald","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105380_bib99","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5271\/sjweh.3641","article-title":"Parkinson's disease and occupational exposures: a systematic literature review and meta-analyses","volume":"43","author":"Gunnarsson","year":"2017","journal-title":"Scand. J. Work. Environ. Health"},{"key":"10.1016\/j.neuint.2022.105380_bib100","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105380_bib101","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.neuropharm.2010.02.002","article-title":"Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain","volume":"58","author":"Hadaczek","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105380_bib102","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ng.642","article-title":"Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease","volume":"42","author":"Hamza","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2022.105380_bib103","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"\u03b1-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuint.2022.105380_bib104","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.molmed.2012.03.002","article-title":"Beyond \u03b1-synuclein transfer: pathology propagation in Parkinson's disease","volume":"18","author":"Hansen","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuint.2022.105380_bib105","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798694","article-title":"LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages","volume":"37","author":"H\u00e4rtlova","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2022.105380_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms10943","article-title":"Promotion of mitochondrial biogenesis by necdin protects neurons against mitochondrial insults","volume":"7","author":"Hasegawa","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2022.105380_bib107","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson's disease: a dual\u2010hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105380_bib108","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/hmg\/ddx167","article-title":"Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans","volume":"26","author":"Hayashi","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2022.105380_bib109","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbrc.2006.01.057","article-title":"Down-regulation of \u03b1-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model","volume":"341","author":"Hayashita-Kinoh","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2022.105380_bib110","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0891-5849(03)00385-X","article-title":"Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys","volume":"35","author":"He","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2022.105380_bib111","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ana.20063","article-title":"A functional polymorphism regulating dopamine \u03b2\u2010hydroxylase influences against Parkinson's disease","volume":"55","author":"Healy","year":"2004","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"10.1016\/j.neuint.2022.105380_bib112","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action and in vivo role of platelet-derived growth factor","volume":"79","author":"Heldin","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuint.2022.105380_bib113","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.parkreldis.2010.06.012","article-title":"Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries","volume":"16","author":"Henry","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib114","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ajim.4700170307","article-title":"Parkinson's disease: a case\u2010control study of occupational and environmental risk factors","volume":"17","author":"Hertzman","year":"1990","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.neuint.2022.105380_bib115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1873-9598(08)70024-3","article-title":"Non-motor symptoms of Parkinson's disease","volume":"1","author":"Hou","year":"2007","journal-title":"Int. J. Gerontol."},{"key":"10.1016\/j.neuint.2022.105380_bib116","first-page":"1","article-title":"The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?","volume":"3","author":"Houser","year":"2017","journal-title":"NPJ Parkinson's dis."},{"key":"10.1016\/j.neuint.2022.105380_bib117","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cell.2004.09.016","article-title":"PGC-1\u03b1: turbocharging mitochondria","volume":"119","author":"Houten","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2022.105380_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26599\/JNR.2019.9040003","article-title":"2018 yearbook of neurorestoratology","volume":"7","author":"Huang","year":"2019","journal-title":"J. Neurorestoratol."},{"key":"10.1016\/j.neuint.2022.105380_bib119","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai7795","article-title":"Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease","volume":"10","author":"Hui","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuint.2022.105380_bib120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fnagi.2016.00196","article-title":"Neuromelanin imaging and dopaminergic loss in Parkinson's disease","volume":"8","author":"Isaias","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib121","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(83)90171-4","article-title":"Loss of pigmented dopamine-\u03b2-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type","volume":"39","author":"Iversen","year":"1983","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2022.105380_bib122","doi-asserted-by":"crossref","first-page":"14063","DOI":"10.1073\/pnas.0900096106","article-title":"Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration","volume":"106","author":"Jang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2022.105380_bib123","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s40572-017-0142-3","article-title":"Outdoor ambient air pollution and neurodegenerative diseases: the neuroinflammation hypothesis","volume":"4","author":"Jayaraj","year":"2017","journal-title":"Curr. Environ. Health Rep."},{"key":"10.1016\/j.neuint.2022.105380_bib124","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"10.1016\/j.neuint.2022.105380_bib125","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbadis.2013.09.007","article-title":"Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes","volume":"1842","author":"Jin","year":"2014","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.neuint.2022.105380_bib126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pneurobio.2016.04.006","article-title":"Microglial phenotypes in Parkinson's disease and animal models of the disease","volume":"155","author":"Joers","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105380_bib127","article-title":"Triggers, facilitators, and aggravators: redefining Parkinson's disease pathogenesis","author":"Johnson","year":"2018","journal-title":"Trends in neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib128","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","article-title":"Triggers, facilitators, and aggravators: redefining Parkinson's disease pathogenesis","volume":"42","author":"Johnson","year":"2019","journal-title":"Trends in neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/ars.2011.4491","article-title":"Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease","volume":"18","author":"Kaidery","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.neuint.2022.105380_bib130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/ane.12563","article-title":"The genetic background of Parkinson's disease: current progress and future prospects","volume":"134","author":"Kalinderi","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuint.2022.105380_bib131","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuroimage.2015.03.020","article-title":"Histologic validation of locus coeruleus MRI contrast in post-mortem tissue","volume":"113","author":"Keren","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuint.2022.105380_bib132","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainres.2011.04.036","article-title":"An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons","volume":"1395","author":"Khodr","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2022.105380_bib133","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ab.2005.07.007","article-title":"Evaluation of RNA isolation procedures from human blood and its application for gene expression studies (Sod-1, Sod-2)","volume":"347","author":"Khymenets","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuint.2022.105380_bib134","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jama.2015.120","article-title":"Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial","volume":"313","author":"Kieburtz","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.neuint.2022.105380_bib135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mds.25150","article-title":"Parkinson's disease: evidence for environmental risk factors","volume":"28","author":"Kieburtz","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120819","article-title":"Genetic and chemical activation of TFEB mediates clearance of aggregated \u03b1-synuclein","volume":"10","author":"Kilpatrick","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2022.105380_bib137","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1073\/pnas.1509742112","article-title":"Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease","volume":"112","author":"Kim","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2022.105380_bib138","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/mds.26755","article-title":"Association between hepatitis C virus infection and Parkinson's disease","volume":"31","author":"Kim","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib139","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mds.28411","article-title":"Genetic and environmental factors in P arkinson's disease converge on immune function and inflammation","volume":"36","author":"Kline","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib140","doi-asserted-by":"crossref","first-page":"16691","DOI":"10.1073\/pnas.1006083107","article-title":"Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function","volume":"107","author":"Ko","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2022.105380_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep44373","article-title":"Nix restores mitophagy and mitochondrial function to protect against PINK1\/Parkin-related Parkinson's disease","volume":"7","author":"Koentjoro","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2022.105380_bib142","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuint.2022.105380_bib143","first-page":"1","article-title":"Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease","volume":"10","author":"Krashia","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2022.105380_bib144","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.envres.2015.05.013","article-title":"Urban air pollution, poverty, violence and health\u2013Neurological and immunological aspects as mediating factors","volume":"140","author":"Kristiansson","year":"2015","journal-title":"Environ. Res."},{"key":"10.1016\/j.neuint.2022.105380_bib145","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/mds.27360","article-title":"Disease modification in Parkinson's disease: current approaches, challenges, and future considerations","volume":"33","author":"Lang","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib146","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputamenal glial cell line\u2013derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib147","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.20834","article-title":"The Parkinson's complex: parkinsonism is just the tip of the iceberg","volume":"59","author":"Langston","year":"2006","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"10.1016\/j.neuint.2022.105380_bib148","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5483\/BMBRep.2014.47.7.086","article-title":"Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases","volume":"47","author":"Lee","year":"2014","journal-title":"BMB reports"},{"key":"10.1016\/j.neuint.2022.105380_bib149","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1074\/jbc.M107421200","article-title":"Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2022.105380_bib150","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of \u03b1-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2022.105380_bib151","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.envint.2016.08.017","article-title":"Traffic-related air pollution increased the risk of Parkinson's disease in Taiwan: a nationwide study","volume":"96","author":"Lee","year":"2016","journal-title":"Environ. Int."},{"key":"10.1016\/j.neuint.2022.105380_bib152","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S1353-8020(11)70022-0","article-title":"Role of Mendelian genes in \u201csporadic\u201d Parkinson's disease","volume":"18","author":"Lesage","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib153","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jnc.12231","article-title":"The role of MAC 1 in diesel exhaust particle\u2010induced microglial activation and loss of dopaminergic neuron function","volume":"125","author":"Levesque","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105380_bib154","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1289\/ehp.1002986","article-title":"Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity","volume":"119","author":"Levesque","year":"2011","journal-title":"Environ. health perspect."},{"key":"10.1016\/j.neuint.2022.105380_bib155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-3-19","article-title":"In vivo silencing of alpha-synuclein using naked siRNA","volume":"3","author":"Lewis","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2022.105380_bib156","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1056\/NEJMct0800326","article-title":"Levodopa for the treatment of Parkinson's disease","volume":"359","author":"Lewitt","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2022.105380_bib157","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of \u03b1-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2022.105380_bib158","first-page":"3558","article-title":"Quercetin induces mitochondrial biogenesis in experimental traumatic brain injury via the PGC-1\u03b1 signaling pathway","volume":"8","author":"Li","year":"2016","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.neuint.2022.105380_bib159","first-page":"1","article-title":"Distribution of \u03b1-synuclein aggregation in the peripheral tissues","author":"Li","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2022.105380_bib160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105380_bib161","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/MIB.0000000000000735","article-title":"Association between Parkinson's disease and inflammatory bowel disease: a nationwide Taiwanese retrospective cohort study","volume":"22","author":"Lin","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.neuint.2022.105380_bib162","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nbd.2016.07.009","article-title":"Unconventional neurotrophic factors CDNF and MANF: structure, physiological functions and therapeutic potential","volume":"97","author":"Lindahl","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2022.105380_bib163","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature05957","article-title":"Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo","volume":"448","author":"Lindholm","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105380_bib164","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.48.6.1583","article-title":"Environmental risk factors and Parkinson's disease: a case\u2010control study in Taiwan","volume":"48","author":"Liou","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105380_bib165","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/cells8070712","article-title":"Mitophagy in Parkinson's disease: from pathogenesis to treatment","volume":"8","author":"Liu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neuint.2022.105380_bib166","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/biom5020435","article-title":"The interplay between alpha-synuclein clearance and spreading","volume":"5","author":"Lopes Da Fonseca","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuint.2022.105380_bib167","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00401-017-1746-2","article-title":"\u03b1-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading","volume":"134","author":"Loria","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2022.105380_bib168","series-title":"Textbook of Stereotactic and Functional Neurosurgery","author":"Lozano","year":"2009"},{"key":"10.1016\/j.neuint.2022.105380_bib169","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12017-009-8108-8","article-title":"From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure","volume":"11","author":"Lucchini","year":"2009","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.neuint.2022.105380_bib170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1871527314666150225124928","article-title":"Inflammatory and cell death pathways in brain and peripheral blood in Parkinson's disease","volume":"14","author":"Macchi","year":"2015","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuint.2022.105380_bib171","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nbd.2006.10.020","article-title":"Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model","volume":"25","author":"Maetzler","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2022.105380_bib172","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/hmg\/ddt674","article-title":"c-Abl phosphorylates \u03b1-synuclein and regulates its degradation: implication for \u03b1-synuclein clearance and contribution to the pathogenesis of Parkinson's disease","volume":"23","author":"Mahul-Mellier","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2022.105380_bib173","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011091","article-title":"Interferon-\u03b3 produced by microglia and the neuropeptide PACAP have opposite effects on the viability of neural progenitor cells","volume":"5","author":"M\u00e4kel\u00e4","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2022.105380_bib174","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2990.1983.tb00320.x","article-title":"Pathological basis for neurotransmitter changes in Parkinson's disease","volume":"9","author":"Mann","year":"1983","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105380_bib175","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.4103\/1673-5374.237108","article-title":"Neuroprotection by immunomodulatory agents in animal models of Parkinson's disease","volume":"13","author":"Martinez","year":"2018","journal-title":"Neural regener. res."},{"key":"10.1016\/j.neuint.2022.105380_bib306","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(91)90345-O","article-title":"Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson\u2019s disease","volume":"41(2-3)","author":"Mavridis","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2022.105380_bib176","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA\u2010DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"Mcgeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105380_bib177","first-page":"474","article-title":"The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease","volume":"51","author":"Menza","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neuint.2022.105380_bib178","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1111\/bph.13192","article-title":"PDE 7 inhibitor TC 3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis","volume":"172","author":"Mestre","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105380_bib179","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","article-title":"Understanding dopaminergic cell death pathways in Parkinson disease","volume":"90","author":"Michel","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2022.105380_bib180","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1073\/pnas.191107398","article-title":"An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease","volume":"98","author":"Mochizuki","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2022.105380_bib181","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1046-2023(02)00229-3","article-title":"Adeno-associated virus-mediated antiapoptotic gene delivery: in vivo gene therapy for neurological disorders","volume":"28","author":"Mochizuki","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.neuint.2022.105380_bib182","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","article-title":"LRRK2 inhibition attenuates microglial inflammatory responses","volume":"32","author":"Moehle","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib183","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-017-0154-3","article-title":"Therapeutic potential of autophagy-enhancing agents in Parkinson's disease","volume":"12","author":"Moors","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2022.105380_bib184","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1126\/science.1249161","article-title":"PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling","volume":"344","author":"Morais","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.neuint.2022.105380_bib185","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.neurobiolaging.2014.10.008","article-title":"Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor Deficits in Hemiparkinsonian Mice","volume":"36","author":"Morales-Garcia","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2022.105380_bib186","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/cn300110c","article-title":"Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo","volume":"3","author":"Morales-Garcia","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib187","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017240","article-title":"Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease","volume":"6","author":"Morales-Garcia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2022.105380_bib188","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/stem.2480","article-title":"Phosphodiesterase7 inhibition activates adult neurogenesis in hippocampus and subventricular zone in vitro and in vivo","volume":"35","author":"Morales\u2010Garcia","year":"2017","journal-title":"Stem Cell."},{"key":"10.1016\/j.neuint.2022.105380_bib189","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00018-011-0850-z","article-title":"Transgenic expression and activation of PGC-1\u03b1 protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease","volume":"69","author":"Mudo","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuint.2022.105380_bib190","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1096\/fj.201500047","article-title":"Microglial priming through the lung\u2014brain axis: the role of air pollution\u2010induced circulating factors","volume":"30","author":"Mumaw","year":"2016","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuint.2022.105380_bib191","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/hmg\/ddu582","article-title":"Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutation p. D620N","volume":"24","author":"Munsie","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2022.105380_bib192","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3389\/fneur.2018.00711","article-title":"Deep brain stimulation and L-dopa therapy: concepts of action and clinical applications in Parkinson's disease","volume":"9","author":"Muthuraman","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib193","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1091\/mbc.e07-11-1103","article-title":"Regulation of mitochondrial morphology by USP30, a deubiquitinating enzyme present in the mitochondrial outer membrane","volume":"19","author":"Nakamura","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neuint.2022.105380_bib194","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib195","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/exnr.2001.7671","article-title":"Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration","volume":"169","author":"Natsume","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib196","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of \u03b1-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2022.105380_bib197","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.60.1.69","article-title":"Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD","volume":"60","author":"Nutt","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105380_bib198","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson's disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. med."},{"key":"10.1016\/j.neuint.2022.105380_bib199","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jnc.13750","article-title":"Current and experimental treatments of Parkinson disease: a guide for neuroscientists","volume":"139","author":"Oertel","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105380_bib200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0006-8993(02)02934-7","article-title":"Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease","volume":"947","author":"Oiwa","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2022.105380_bib201","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.med.55.091902.104422","article-title":"The scientific basis for the current treatment of Parkinson's disease","volume":"55","author":"Olanow","year":"2004","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuint.2022.105380_bib202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/mds.26119","article-title":"Levodopa: effect on cell death and the natural history of Parkinson's disease","volume":"30","author":"Olanow","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib203","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","article-title":"The scientific and clinical basis for the treatment of Parkinson disease (2009)","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105380_bib204","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.neurobiolaging.2014.04.032","article-title":"Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice","volume":"35","author":"Oliveras-Salv\u00e1","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2022.105380_bib205","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1016\/S1353-8020(09)70814-4","article-title":"Neuroinflammation in the living brain of Parkinson's disease","volume":"15","author":"Ouchi","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib206","first-page":"14","article-title":"Pesticides trigger Parkinson's disease","volume":"28","author":"Owens","year":"2008","journal-title":"Pesticides and You"},{"key":"10.1016\/j.neuint.2022.105380_bib207","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mehy.2013.11.016","article-title":"Uptake of environmental toxicants by the locus ceruleus: a potential trigger for neurodegenerative, demyelinating and psychiatric disorders","volume":"82","author":"Pamphlett","year":"2014","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuint.2022.105380_bib208","doi-asserted-by":"crossref","DOI":"10.1038\/npre.2010.3352.3","article-title":"Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice","author":"Pan-Montojo","year":"2010","journal-title":"Nat. Proc."},{"key":"10.1016\/j.neuint.2022.105380_bib209","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial dysfunction in Parkinson's disease: new mechanistic insights and therapeutic perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuint.2022.105380_bib210","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann. Neurol.: Official Journal of the american neurological Association and the child Neurology Society"},{"key":"10.1016\/j.neuint.2022.105380_bib211","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.20374","article-title":"Intraputamenal infusion of glial cell line\u2013derived neurotrophic factor in PD: a two\u2010year outcome study","volume":"57","author":"Patel","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib212","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/sj.mt.6300067","article-title":"DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice","volume":"15","author":"Paterna","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neuint.2022.105380_bib213","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI79635","article-title":"Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients","volume":"125","author":"Paul","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuint.2022.105380_bib214","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.neurobiolaging.2013.03.011","article-title":"Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease","volume":"34","author":"PErez-Gonzalez","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2022.105380_bib215","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","article-title":"Anti\u2013tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease","volume":"75","author":"Peter","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib216","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175882","article-title":"Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes","volume":"12","author":"Pierce","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2022.105380_bib217","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3940(96)12326-0","article-title":"Protective effect of platelet-derived growth factor against 6-hydroxydopamine-induced lesion of rat dopaminergic neurons in culture","volume":"204","author":"Pietz","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2022.105380_bib218","article-title":"Poewe W et al., Parkinson disease","volume":"3","author":"Pirker","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.neuint.2022.105380_bib219","doi-asserted-by":"crossref","first-page":"10481","DOI":"10.1073\/pnas.1804198115","article-title":"Small molecule inhibits \u03b1-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons","volume":"115","author":"Pujols","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2022.105380_bib220","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/gim.2012.107","article-title":"Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling","volume":"15","author":"Rana","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.neuint.2022.105380_bib221","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.10513","article-title":"Limitations of current Parkinson's disease therapy","volume":"53","author":"Rascol","year":"2003","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"10.1016\/j.neuint.2022.105380_bib222","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2174\/138161211795589355","article-title":"Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo","volume":"17","author":"Reglodi","year":"2011","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.neuint.2022.105380_bib223","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S1474-4422(18)30355-7","article-title":"The burden of Parkinson's disease: a worldwide perspective","volume":"17","author":"Rocca","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib224","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2022.105380_bib225","doi-asserted-by":"crossref","first-page":"13804","DOI":"10.1073\/pnas.0702753104","article-title":"Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice","volume":"104","author":"Rommelfanger","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2022.105380_bib226","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2004.02785.x","article-title":"Reduced MPTP toxicity in noradrenaline transporter knockout mice","volume":"91","author":"Rommelfanger","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105380_bib227","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1046\/j.1460-9568.1999.00566.x","article-title":"Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle","volume":"11","author":"Rosenblad","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib228","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.20226","article-title":"Parkinsonian signs and substantia nigra neuron density in decendents elders without PD","volume":"56","author":"Ross","year":"2004","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"10.1016\/j.neuint.2022.105380_bib229","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/jcbfm.2014.236","article-title":"Enhanced delivery and bioactivity of the neurturin neurotrophic factor through focused ultrasound\u2014mediated blood\u2014brain barrier opening in vivo","volume":"35","author":"Samiotaki","year":"2015","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuint.2022.105380_bib230","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2022.105380_bib231","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.neuro.2012.08.012","article-title":"Manganese mixture inhalation is a reliable Parkinson disease model in rats","volume":"33","author":"Sanchez-Betancourt","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2022.105380_bib232","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2014.04.003","article-title":"The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse","volume":"68","author":"Savolainen","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2022.105380_bib233","unstructured":"Say, W. DELAYED on \u201cYou Might Notice it May Take a while for Your Symptoms to Improve after You Take a Dose of Levodopa\u2014This Is Called a \u2018delayed ON.\u2019\u201d 8, 10 \u201cIt Feels like It\u2019sa Long Time before a Levodopa Dose Takes Effect. How Long Should it Take?\u201d."},{"key":"10.1016\/j.neuint.2022.105380_bib234","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/jnnp.2004.035980","article-title":"Present and future drug treatment for Parkinson's disease","volume":"76","author":"Schapira","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neuint.2022.105380_bib235","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1073\/pnas.1300822110","article-title":"Glucocerebrosidase in the pathogenesis and treatment of Parkinson disease","volume":"110","author":"Schapira","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2022.105380_bib236","series-title":"The Prodromal Microbiome","author":"Scheperjans","year":"2018"},{"key":"10.1016\/j.neuint.2022.105380_bib237","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.tcb.2013.04.010","article-title":"Retromer-mediated endosomal protein sorting: all WASHed up","volume":"23","author":"Seaman","year":"2013","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuint.2022.105380_bib238","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jnr.490350109","article-title":"Infusion of iron into the rat substantia nigra: nigral pathology and dose\u2010dependent loss of striatal dopaminergic markers","volume":"35","author":"Sengstock","year":"1993","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2022.105380_bib239","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuint.2022.105380_bib240","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1474-4422(21)00219-2","article-title":"Parkinson's disease outside the brain: targeting the autonomic nervous system","volume":"20","author":"Sharabi","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib241","first-page":"131","volume":"vol. 5","author":"Shill","year":"1998"},{"key":"10.1016\/j.neuint.2022.105380_bib242","doi-asserted-by":"crossref","first-page":"12833","DOI":"10.1523\/JNEUROSCI.0109-15.2015","article-title":"Mitochondrial quality control via the PGC1\u03b1-TFEB signaling pathway is compromised by Parkin Q311X mutation but independently restored by rapamycin","volume":"35","author":"Siddiqui","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib243","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2022.105380_bib244","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.neuint.2022.105380_bib245","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3171\/jns.2005.102.2.0216","article-title":"Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line\u2014derived neurotrophic factor","volume":"102","author":"Slevin","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuint.2022.105380_bib246","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A double\u2010blind, placebo\u2010controlled study to assess the mitochondria\u2010targeted antioxidant MitoQ as a disease\u2010modifying therapy in Parkinson's disease","volume":"25","author":"Snow","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib247","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in \u03b1-synuclein models of Parkinson's and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib248","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1046\/j.1460-9568.2003.02684.x","article-title":"Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6\u2010hydroxydopamine\u2010induced partial degeneration of substantia nigra in rats","volume":"17","author":"Srinivasan","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib249","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/mds.20383","article-title":"Identification of motor and nonmotor wearing\u2010off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment Movement disorders","volume":"20","author":"Stacy","year":"2005","journal-title":"Mov. Disord. off. j. Mov. Disord. Soc."},{"key":"10.1016\/j.neuint.2022.105380_bib250","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1471-4159.2009.06145.x","article-title":"Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia","volume":"110","author":"Stanwood","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105380_bib251","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ajpath.2011.04.013","article-title":"Toll-like receptor 4 promotes \u03b1-synuclein clearance and survival of nigral dopaminergic neurons","volume":"179","author":"Stefanova","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuint.2022.105380_bib252","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1134\/S0006297914050022","article-title":"Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases","volume":"79","author":"Stelmashook","year":"2014","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.neuint.2022.105380_bib253","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.parkreldis.2013.10.027","article-title":"Early DEtection of wEaring off in Parkinson disease: the DEEP study","volume":"20","author":"Stocchi","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib254","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000477990","article-title":"A role for neuronal alpha-synuclein in gastrointestinal immunity","volume":"9","author":"Stolzenberg","year":"2017","journal-title":"J. innate immun."},{"key":"10.1016\/j.neuint.2022.105380_bib255","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1096\/fj.201700759RR","article-title":"Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease","volume":"32","author":"Stykel","year":"2018","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuint.2022.105380_bib256","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","article-title":"Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease","volume":"45","author":"Sun","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuint.2022.105380_bib257","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.expneurol.2017.08.001","article-title":"Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease","volume":"298","author":"Surmeier","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib258","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-2094-8-91","article-title":"The PPAR-\u03b3 agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys","volume":"8","author":"Swanson","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuint.2022.105380_bib259","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1523\/JNEUROSCI.4265-05.2006","article-title":"Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies","volume":"26","author":"Szot","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib260","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archneur.57.5.729","article-title":"Clinical characteristics of pramipexole-induced peripheral edema","volume":"57","author":"Tan","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib261","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.39.5.660","article-title":"Environmental factors and Parkinson's disease: a case\u2010control study in China","volume":"39","author":"Tanner","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105380_bib262","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson's disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. health perspect."},{"key":"10.1016\/j.neuint.2022.105380_bib263","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archneurol.2009.195","article-title":"Occupation and risk of parkinsonism: a multicenter case-control study","volume":"66","author":"Tanner","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib264","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1471-4159.1994.62010134.x","article-title":"Increased iron in the substantia nigra compacta of the MPTP\u2010lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis","volume":"62","author":"Temlett","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105380_bib265","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/mds.26185","article-title":"USP30: a new promising target for Parkinson's disease? Movement disorders","volume":"30","author":"Thobois","year":"2015","journal-title":"Mov. Disord. off. j. Mov. Disord. Soc."},{"key":"10.1016\/j.neuint.2022.105380_bib266","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/archneur.63.12.1724","article-title":"Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline","volume":"63","author":"Tong","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib267","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.celrep.2014.05.033","article-title":"\u03b1-Synuclein immunotherapy blocks uptake and templated propagation of misfolded \u03b1-synuclein and neurodegeneration","volume":"7","author":"Tran","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuint.2022.105380_bib268","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-019-0314-8","article-title":"Glial phagocytic clearance in Parkinson's disease","volume":"14","author":"Tremblay","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2022.105380_bib269","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/B978-0-12-410502-7.00013-2","article-title":"Manganese and the brain","volume":"110","author":"Tuschl","year":"2013","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105380_bib270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12989-016-0177-x","article-title":"Surface area-dependence of gas-particle interactions influences pulmonary and neuroinflammatory outcomes","volume":"13","author":"Tyler","year":"2016","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.neuint.2022.105380_bib271","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2022.105380_bib272","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/jnc.13449","article-title":"Sorting out release, uptake and processing of alpha\u2010synuclein during prion\u2010like spread of pathology","volume":"139","author":"Tyson","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105380_bib273","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human \u03b1-synuclein a possible molecular link between Parkinson' s disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2022.105380_bib274","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3390\/ijms20030719","article-title":"Approaches for the treatment of alzheimer's and Parkinson's disease","volume":"20","author":"Van Bulck","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2022.105380_bib275","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/hmg\/ddt570","article-title":"DNAJC13 mutations in Parkinson disease","volume":"23","author":"Vilari\u00f1o-G\u00fcell","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2022.105380_bib276","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","article-title":"VPS35 mutations in Parkinson disease","volume":"89","author":"Vilari\u00f1o-G\u00fcell","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuint.2022.105380_bib277","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gutjnl-2017-315666","article-title":"Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977\u20132014","volume":"68","author":"Villumsen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.neuint.2022.105380_bib278","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","article-title":"G2019S-LRRK2 expression augments \u03b1-synuclein sequestration into inclusions in neurons","volume":"36","author":"Volpicelli-Daley","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib279","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1474-4422(15)00186-6","article-title":"Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson's disease","volume":"14","author":"Volta","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib280","doi-asserted-by":"crossref","first-page":"9651","DOI":"10.1523\/JNEUROSCI.0833-09.2009","article-title":"Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease","volume":"29","author":"Voutilainen","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib281","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2022.105380_bib282","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10654-011-9574-5","article-title":"Parkinson's disease risk from ambient exposure to pesticides","volume":"26","author":"Wang","year":"2011","journal-title":"Eur. j. epidemiol."},{"key":"10.1016\/j.neuint.2022.105380_bib283","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.1523\/JNEUROSCI.1134-18.2018","article-title":"14-3-3 proteins reduce cell-to-cell transfer and propagation of pathogenic \u03b1-synuclein","volume":"38","author":"Wang","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib284","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13000-016-0459-5","article-title":"Beclin1 and HMGB1 ameliorate the \u03b1-synuclein-mediated autophagy inhibition in PC12 cells","volume":"11","author":"Wang","year":"2016","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.neuint.2022.105380_bib285","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1073\/pnas.1610099113","article-title":"Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein \u03b1-synuclein","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2022.105380_bib286","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/15548627.2015.1034408","article-title":"Deubiquitinating enzymes regulate PARK2-mediated mitophagy","volume":"11","author":"Wang","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.neuint.2022.105380_bib287","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ibd\/izy190","article-title":"Inflammatory bowel disease and Parkinson's disease: a nationwide Swedish cohort study","volume":"25","author":"Weimers","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.neuint.2022.105380_bib288","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF02260941","article-title":"Intranigral injected iron progressively reduces striatal dopamine metabolism","volume":"8","author":"Wesemann","year":"1994","journal-title":"J. Neural Transm. - Parkinson's Dis. Dementia Sect. (JNT)"},{"key":"10.1016\/j.neuint.2022.105380_bib289","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.expneurol.2017.07.019","article-title":"Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease","volume":"298","author":"West","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib290","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/mds.26563","article-title":"S erum immune markers and disease progression in an incident P arkinson's disease cohort (ICICLE\u2010PD)","volume":"31","author":"Williams\u2010Gray","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105380_bib291","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/aje\/kwq303","article-title":"Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems","volume":"172","author":"Willis","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neuint.2022.105380_bib292","doi-asserted-by":"crossref","first-page":"16906","DOI":"10.1523\/JNEUROSCI.2723-12.2012","article-title":"Role of \u03b1-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus","volume":"32","author":"Winner","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105380_bib293","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10654-011-9581-6","article-title":"Epidemiology and etiology of Parkinson's disease: a review of the evidence","volume":"26","author":"Wirdefeldt","year":"2011","journal-title":"Eur. j. epidemiol."},{"key":"10.1016\/j.neuint.2022.105380_bib294","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1212\/WNL.59.3.408","article-title":"Nonmotor fluctuations in Parkinson's disease: frequent and disabling","volume":"59","author":"Witjas","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105380_bib295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. med."},{"key":"10.1016\/j.neuint.2022.105380_bib296","doi-asserted-by":"crossref","first-page":"10433","DOI":"10.1073\/pnas.181182298","article-title":"Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease","volume":"98","author":"Xia","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2022.105380_bib297","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainres.2015.08.032","article-title":"Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson\u05f3 s disease","volume":"1625","author":"Yao","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2022.105380_bib298","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/NEN.0b013e3182269ecd","article-title":"Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease","volume":"70","author":"Yasuda","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib299","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JPD-2011-0003","article-title":"Restorative effects of platelet derived growth factor-BB in rodent models of Parkinson's disease","volume":"1","author":"Zachrisson","year":"2011","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuint.2022.105380_bib300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-069X-13-38","article-title":"A national case-crossover analysis of the short-term effect of PM2. 5 on hospitalizations and mortality in subjects with diabetes and neurological disorders","volume":"13","author":"Zanobetti","year":"2014","journal-title":"Environ. Health"},{"key":"10.1016\/j.neuint.2022.105380_bib301","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2022.105380_bib302","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.omtn.2017.08.002","article-title":"LRRK2 antisense oligonucleotides ameliorate \u03b1-synuclein inclusion formation in a Parkinson's disease mouse model","volume":"8","author":"Zhao","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.neuint.2022.105380_bib303","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1750-3639.2003.tb00478.x","article-title":"Localization of phosphorylated ERK\/MAP kinases to mitochondria and autophagosomes in Lewy body diseases","volume":"13","author":"Zhu","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuint.2022.105380_bib304","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","article-title":"A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease","volume":"89","author":"Zimprich","year":"2011","journal-title":"Am. J. Hum. Genet."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019701862200105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019701862200105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:01:01Z","timestamp":1759312861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019701862200105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":305,"alternative-id":["S019701862200105X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2022.105380","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective approaches to halt Parkinson's disease progression","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2022.105380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105380"}}